» Articles » PMID: 18618831

Modeling and Optimization of the Baculovirus Expression Vector System in Batch Suspension Culture

Overview
Publisher Wiley
Specialty Biochemistry
Date 1994 Sep 5
PMID 18618831
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

A mathematical model has been developed that predicts the cell population dynamics and production of recombinant protein and infective extracellular virus progeny by insect cells after infection with baculovirus in batch suspension culture. Infection in the model is based on the rate of virus attachment to suspended insect cells under culture conditions. The model links the events following infection with the sequence of gene expression in the baculovirus replicative cycle. Substrate depletion is used to account for the decrease in product yield observed when infecting at high cell densities. Model parameters were determined in shaker flasks for two media: serum-supplemented IPL-41 medium and serum free Sf900II medium. There was good agreement between model predictions and the results from an independent series of experiments performed to validate the mode. The model predicted: (1) the optimal time of infection at high multiplicity of infection: (2) the timing and magnitude of recombinant protein production in a 2-L bioreactor; and (3) the timing and magnitude of recombinant protein production at multiplicities of infection from 0.01 to 100 plaque-forming units per cell. Through its ability to predict optimal infection strategies in batch suspension culture, the model has use in the design and optimization of large-scale systems for the production of recombinant products using the baculovirus expression vector system.

Citing Articles

Mechanistic modeling explains the production dynamics of recombinant adeno-associated virus with the baculovirus expression vector system.

Destro F, Joseph J, Srinivasan P, Kanter J, Neufeld C, Wolfrum J Mol Ther Methods Clin Dev. 2023; 30:122-146.

PMID: 37746245 PMC: 10512016. DOI: 10.1016/j.omtm.2023.05.019.


Platforms, advances, and technical challenges in virus-like particles-based vaccines.

Gupta R, Arora K, Roy S, Joseph A, Rastogi R, Mehrotra Arora N Front Immunol. 2023; 14:1123805.

PMID: 36845125 PMC: 9947793. DOI: 10.3389/fimmu.2023.1123805.


Sf9 Cells Metabolism and Viability When Coinfected with Two Monocistronic Baculoviruses to Produce Rabies Virus-like Particles.

Leme J, Oliveira Guardalini L, Consoni Bernardino T, Mancini Astray R, Tonso A, Fernandez Nunez E Mol Biotechnol. 2022; 65(6):970-982.

PMID: 36396754 PMC: 9672645. DOI: 10.1007/s12033-022-00586-x.


Evaluation of screening platforms for virus-like particle production with the baculovirus expression vector system in insect cells.

Strobl F, Ghorbanpour S, Palmberger D, Striedner G Sci Rep. 2020; 10(1):1065.

PMID: 31974440 PMC: 6978312. DOI: 10.1038/s41598-020-57761-w.


A viral expression factor behaves as a prion.

Nan H, Chen H, Tuite M, Xu X Nat Commun. 2019; 10(1):359.

PMID: 30664652 PMC: 6341119. DOI: 10.1038/s41467-018-08180-z.